Inhibition of Human Telomerase by a G-Quadruplex-Interactive Compound
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVLetterNEXTInhibition of Human Telomerase by a G-Quadruplex-Interactive CompoundDaekyu Sun, Brian Thompson, Brian E. Cathers, Miguel Salazar, Sean M. Kerwin, John O. Trent, Terence C. Jenkins, Stephen Neidle, and Laurence H. HurleyView Author Information Institute for Drug Development, 14960 Omicron Drive, San Antonio, Texas 78245-3217, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712-1074, and CRC Biomolecular Structure Unit, The Institute of Cancer Research, Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom Cite this: J. Med. Chem. 1997, 40, 14, 2113–2116Publication Date (Web):July 4, 1997Publication History Received25 March 1997Published online4 July 1997Published inissue 1 July 1997https://pubs.acs.org/doi/10.1021/jm970199zhttps://doi.org/10.1021/jm970199zrapid-communicationACS PublicationsCopyright © 1997 American Chemical SocietyRequest reuse permissionsArticle Views5835Altmetric-Citations687LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-AlertscloseSupporting Info (1)»Supporting Information Supporting Information SUBJECTS:Chemical structure,G-Quadruplex,Genetics,Inhibition,Peptides and proteins Get e-Alerts
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several strategies to inhibit telomerase activity have been reported.These include peptide nucleic acids and 2¢-O-MeRNA oligonucleotides directed towards the telomerase RNA template (Herbert et al., 1999), compounds that target telomeric DNA such as cationic porphyrins or anthraquinones (Sun et al., 1997) and nucleosidic reverse transcriptase inhibitors (Strahl and Blackburn, 1996).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Sun et al., 1997
Citations
Cites
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Structure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Inhibition of telomerase by G-quartet DMA structures
Zahler, A. M., Williamson, J. R., Cech, T. R., & Prescott, D. M. (1991) · Nature · doi:10.1038/350718a0 · Cited by 1,134
Divne, C., Ståhlberg, J., Reinikainen, T., Ruohonen, L., Pettersson, G., Knowles, J. K. C., Teeri, T. T., & Jones, T. A. (1994) · Science · doi:10.1126/science.8036495 · Cited by 626
Correlating telomerase activity levels with human neuroblastoma outcomes
Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., & Shay, J. W. (1995) · Nature Medicine · doi:10.1038/nm0395-249 · Cited by 611
Crystal structure of four-stranded Oxytricha telomeric DNA
Kang, C., Zhang, X., Ratliff, R., Moyzis, R., & Rich, A. (1992) · Nature · doi:10.1038/356126a0 · Cited by 555
The High-Resolution Crystal Structure of a Parallel-Stranded Guanine Tetraplex
Laughlan, G., Murchie, A. I. H., Norman, D. G., Moore, M. H., Moody, P. C. E., Lilley, D. M. J., & Luisi, B. (1994) · Science · doi:10.1126/science.8036494 · Cited by 482
Telomerase Activity in Small-Cell and Non-Small-Cell Lung Cancers
Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A., & Shay, J. W. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.12.895 · Cited by 440
Research works printed but not linked: 10
- Telomeres, 1995, Cold Spring Harbor Press: New York
- Harley C. B., 1994, Cancer. Cold Spring Harbor Symp. Quant. Biol.
- Broccoli D., 1994, Proc. Natl. Acad. Sci. U.S.A., 92, 9086
- Rhyu M. S., 1995, J. Natl. Cancer Inst., 87, 894
- Salazar M., 1996, Biochemistry, 35, 16115
- Fox K. R., 1995, Proc. Natl. Acad. Sci. U.S.A., 92, 7891
- Haq I., 1996, J. Am. Chem. Soc., 118, 10701
- Tanious F. A., 1992, Biochemistry, 31, 11640
- Wang Y., 1992, Biochemistry, 31, 8119
- Chen Q., 1996, Proc. Natl. Acad. Sci. U.S.A., 93, 2639
Cited by
Items 501–600 of 828
Zhang, Y.-L., Deng, C.-X., Zhou, W., Zhou, L.-Y., Cao, Q., Shen, W., Liang, H., & Chen, Z. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110820 · Cited by 17
Ganegamage, S. K., & Heagy, M. D. (2022) · Current Organic Chemistry · doi:10.2174/1385272826666220811102939 · Cited by 18
Structural insights into G-quadruplex binding by metal complexes: implications for drug design
Otoya, T. D. P., McQuaid, K. T., & Cardin, C. J. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03309-w · Cited by 16
“Aided by a structure-based approach to drug development and spurred on previous investigations with triplex interactions, they discovered that a class of compounds, the 2,6-diamidoanthraquinones, were potent G4 binders which disturbed the enzymatic action of telomerase (IC 50 of 23 µm) [50].”
Dynamic topology of double-stranded telomeric DNA studied by single-molecule manipulation in vitro
Zhang, X., Zhang, Y., & Zhang, W. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa479 · Cited by 16
Xanthene and Xanthone Derivatives as G-Quadruplex Stabilizing Ligands
Altieri, A., Alvino, A., Ohnmacht, S. A., Ortaggi, G., Neidle, S., Nocioni, D., Franceschin, M., & Bianco, A. (2013) · Molecules · doi:10.3390/molecules181113446 · Cited by 16
“The first G-quadruplex binding ligand having an effect on telomerase activity was discovered in 1997 as a result of the collaboration between the Neidle and Hurley groups [1,2].”
BackgroundSelf-citationZhang, Q., Cui, X., Lin, S., Zhou, J., & Yuan, G. (2012) · Organic Letters · doi:10.1021/ol302918f · Cited by 16
Anjong, T. F., Kim, G., Jang, H. Y., Yoon, J., & Kim, J. (2016) · New Journal of Chemistry · doi:10.1039/c6nj02890j · Cited by 16
A new class of quadruplex DNA-binding nickel Schiff base complexes
Pham, S. Q. T., Assadawi, N., Wells, J., Sophocleous, R. A., Davis, K. J., Yu, H. B., Sluyter, R., Dillon, C. T., Kelso, C., Beck, J. L., et al. (2020) · Dalton Transactions · doi:10.1039/d0dt00319k · Cited by 16
Chemical biology on the genome
Balasubramanian, S. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.05.016 · Cited by 15
Dey, A., Pandav, K., Nath, M., Barthwal, R., & Prasad, R. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.11.008 · Cited by 15
“The first discovered 2, 6-disubstituted aminoalkyl amido anthraquinone show an affinity for G-quadruplex and inhibits telomerase at 23 mM and DTm 20 C.(19) In peptidyl-anthraquinones, adding a hydrophobic residue (Phe) to the Lys residue at the 2, 6, or 2, 7 locations results in more excellent selectivity for G-quadru…”
BackgroundRoles of G4-DNA and G4-RNA in Class Switch Recombination and Additional Regulations in B-Lymphocytes
Dézé, O., Laffleur, B., & Cogné, M. (2023) · Molecules · doi:10.3390/molecules28031159 · Cited by 15
Kaiser, C. E., Gokhale, V. M., Yang, D., & Hurley, L. H. (2012) · Topics in current chemistry · doi:10.1007/128_2012_333 · Cited by 15
Self-citationXing, M., Zhao, T., Ren, Y., Peng, N.-N., Yang, X., Li, X., Zhang, H., Liu, G.-Q., Zhang, L., & Zhu, H. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-0909-0 · Cited by 15
G-Quadruplexes—Novel Mediators of Gene Function
Zhou, W., Brand, N. J., & Ying, L. (2011) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-011-9258-2 · Cited by 15
“For example, UV melting is used to determine the melting temperature (Tm )o f G4 DNA (see [ 20 ] for examples).”
MethodTelomerase as a new target for pancreatic cancer treatment
Sato, N., Mizumoto, K., Nagai, E., & Tanaka, M. (2002) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340200036 · Cited by 16
Ramos, C. I. V., Almodôvar, V. A. S., Candeias, N. R., Santos, T. A. B. D., Cruz, C., Neves, M. G. P. M. S., & Tomé, A. C. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105703 · Cited by 15
Therapeutic Targets and Drugs II: G-Quadruplex and G-Quadruplex Inhibitors
Punchihewa, C., & Yang, D. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-879-9_11 · Cited by 18
Resolution of Quadruplex Polymorphism by Size‐Exclusion Chromatography
Miller, M. C., & Trent, J. O. (2011) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc1703s45 · Cited by 15
“The first successful application of this concept was the discovery of a bisamidoanthroquinone that was shown to inhibit human telomerase by binding to and stabilizing a G-quadruplex formed in the human telomere (Sun et al., 1997).”
Self-citationSolid-Phase Synthesis of Symmetrical 3,6-Bispeptide−Acridone Conjugates
Ladame, S., Harrison, R. J., Neidle, S., & Balasubramanian, S. (2002) · Organic Letters · doi:10.1021/ol026130p · Cited by 15
Self-citationMolecular modeling of drug-DNA complexes: An update
Trent, J. O. (2001) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(01)40428-9 · Cited by 15
Self-citationG-quadruplex in hepatitis B virus pregenomic RNA promotes its translation
Wang, J., Huang, H., Zhao, K., Teng, Y., Zhao, L., Xu, Z., Zheng, Y., Zhang, L., Li, C., Duan, Y., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105151 · Cited by 14
“(15), 5,10,15,20-tetrakis-(N-methyl-4-pyridyl) porphine (TMPyP4) (16), pyridostatin (PDS) (17), and bisquinolinium derivatives (18).”
BackgroundLaguerre, A., Chang, Y., Pirrotta, M., Desbois, N., Gros, C. P., Lesniewska, É., & Monchaud, D. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00692a · Cited by 14
A Personal History of Quadruplex–Small Molecule Targeting
Neidle, S. (2015) · The Chemical Record · doi:10.1002/tcr.201500011 · Cited by 14
Self-citationFuran based cyclic homo-oligopeptides bind G-quadruplex selectively and repress c-MYC transcription
Agarwal, T., Roy, S., Chakraborty, T. K., & Maiti, S. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.080 · Cited by 14
Nagesh, N., Krishnaiah, A., Dhople, V. M., Sundaram, C. S., & Jagannadham, M. V. (2007) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770701257590 · Cited by 16
“There are reports earlier that small molecules interact specifically with quadruplex structures and stabilize them by stacking externally.[ 19 ] We have studied some of the salient features of quadruplex complex stability when it interacts with drugs and ion.[20–22] In the present”
BackgroundLi, H., Hai, J., Zhou, J., & Yuan, G. (2015) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.7454 · Cited by 14
Insulin-like growth factor type I selectively binds to G-quadruplex structures
Chen, H., Sun, H., Chai, Y., Zhang, S., Guan, A., Li, Q., Yao, L., & Tang, Y. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.09.022 · Cited by 14
Modulating gene expression in breast cancer via DNA secondary structure and the CRISPR toolbox
Kretzmann, J. A., Irving, K. L., Smith, N. M., & Evans, C. W. (2021) · NAR Cancer · doi:10.1093/narcan/zcab048 · Cited by 14
Błasiak, J., Kadłubek, M., Kowalik, J., Romanowicz‐Makowska, H., & Pertyński, T. (2001) · Teratogenesis Carcinogenesis and Mutagenesis · doi:10.1002/tcm.1040 · Cited by 14
Canales, B. K., Li, Y., Thompson, M. G., Gleason, J. M., Chen, Z., Malaeb, B. S., Corey, D. R., Herbert, B., Shay, J. W., & Koeneman, K. S. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.11.003 · Cited by 15
DNA G-quadruplexes: Structural and functional insights
Jonchhe, S., Lahiri, S., & Rothenberg, E. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103910 · Cited by 17
Katsuda, Y., Sato, S., Inoue, M., Tsugawa, H., Kamura, T., Kida, T., Matsumoto, R., Asamitsu, S., Shioda, N., Shiroto, S., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac580 · Cited by 13
Dey, A., Pandav, K., Nath, M., Barthwal, R., & Prasad, R. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.08.156 · Cited by 13
Roy, S., Muniyappa, K., & Bhattacharya, S. (2022) · ChemMedChem · doi:10.1002/cmdc.202200436 · Cited by 13
Telomere components as potential therapeutic targets for treating microbial pathogen infections
Li, B. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00156 · Cited by 14
“Other small molecule inhibitors that interact with the human telomeric DNA are available (Sun et al., 1997), but they may not inhibit parasites other than T. brucei due to telomere sequence dissimilarity.”
BackgroundPOT1 stability and binding measured by fluorescence thermal shift assays
DeLeeuw, L. W., Monsen, R. C., Petrauskas, V., Gray, R. D., Baranauskienė, L., Matulis, D., Trent, J. O., & Chaires, J. B. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245675 · Cited by 13
“G4 DNA has been proposed as a novel drug target [46, 54, 55].”
BackgroundSelf-citationA Small Molecule Inhibitor of Pot1 Binding to Telomeric DNA
Altschuler, S. E., Croy, J. E., & Wuttke, D. S. (2012) · Biochemistry · doi:10.1021/bi300365k · Cited by 13
Critical appraisals of approaches for predictive designs in anticancer drugs
Gnewuch, C. T., & SOSNOVSKY, G. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8483-x · Cited by 13
Tamura, Y., Tao, M., Miyano‐Kurosaki, N., Takai, K., & TAKAKU, H. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.87 · Cited by 13
Gai, W., Yang, Q., Xiang, J., Yu, L., Guan, A., Li, Q., Sun, H., Shang, Q., Jiang, W., Zhang, H., et al. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp44387f · Cited by 12
Sarkar, S., & Singh, P. C. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp03730g · Cited by 12
Fang, S., Liu, S., Yang, D., Yang, L., Hu, C., & Wan, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.957023 · Cited by 13
“Many telomere-associated proteins could interact with G4 structures to prevent telomerase-mediated extensions at the telomeric ends and then repress cell growth (Sun et al., 1997; Fouquerel et al., 2016).”
BackgroundLiu, T., Wu, Y., Qin, L., Luo, Q., Li, W., Cheng, Y., Tu, Y., & You, H. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c03031 · Cited by 13
Cui, X., Zhang, Q., Chen, H., Zhou, J., & Yuan, G. (2014) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-013-0802-y · Cited by 12
Changenet‐Barret, P., Gustavsson, T., Markovitsi, D., & Manet, I. G. J. (2016) · ChemPhysChem · doi:10.1002/cphc.201501091 · Cited by 12
Gao, Y., Wu, S., & Ye, X. (2016) · Soft Matter · doi:10.1039/c6sm01010e · Cited by 12
Roy, S., & Bhattacharya, S. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01500 · Cited by 12
Qualitative SERS analysis of G-quadruplex DNAs using selective stabilising ligands
Gracie, K., Dhamodharan, V., Pradeepkumar, P. I., Faulds, K., & Graham, D. (2014) · The Analyst · doi:10.1039/c4an00551a · Cited by 12
Aghaei, R., Mazloum‐Ardakani, M., Abdollahi‐Alibeik, M., Moshtaghioun, S. M., Rezaeipoor‐Anari, A., Haghighijoo, Z., & Zamani, L. (2017) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2017.04.055 · Cited by 12
Mandal, P., Sahoo, D., Saha, S., & Chowdhury, J. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b07856 · Cited by 12
Huang, H., Chiu, H., Tao, C., & Chen, I. (2006) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.54.458 · Cited by 12
Dastan, D., Soleymanekhtiari, S., & Ebadi, A. (2024) · Protein and Peptide Letters · doi:10.2174/0109298665305131240404072542 · Cited by 14
Molecular mechanisms behind BRACO19 and human telomeric G-quadruplex interaction
Libera, V., Fasolato, C., Ripanti, F., Catalini, S., Bertini, L., Petrillo, C., Schirò, G., D’Amico, F., Rossi, B., Paciaroni, A., et al. (2024) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2024.124684 · Cited by 11
Triazolyl Dibenzo[a,c]phenazines Stabilize Telomeric G‐quadruplex and Inhibit Telomerase
Pal, S., Fatma, K., Ravichandiran, V., & Dash, J. (2021) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.202100468 · Cited by 11
Zhang, J., Wang, T., Geng, X., Liu, L., & Gao, J. (2022) · Molecular Informatics · doi:10.1002/minf.202200011 · Cited by 11
Chromatin as a Target for the DNA-Binding Anticancer Drugs
Majumder, P., Pradhan, S. K., Devi, P. G., Pal, S., & Dasgupta, D. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5466-1_8 · Cited by 13
“For instance, 2,6-diamidoanthraquinone BSU1051 has been found to interact with and stabilize the G-quartet, and thereby inhibit telomerase activity (Sun et al., 1997).”
BackgroundChang, L.-C., Chen, T., Chen, S.-J., Chen, C., Lee, C.-C., Wu, S., Yen, Y., Huang, H., & Lin, J. (2015) · Oncotarget · doi:10.18632/oncotarget.6622 · Cited by 11
Conformational change of a G-quadruplex under molecular crowding conditions
Han, J. H., Kim, J. H., Kim, S. K., & Jang, Y. J. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1662846 · Cited by 11
“In addition, stabilization of the Gquadruplex by many small molecules was shown to inhibit the telomerase activity (Sun et al., 1997).”
BackgroundWang, Y., Guo, L., Meng, T., Qi, L., Yan, H., & Wang, Z. (2021) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2021.108058 · Cited by 11
Song, K., Chen, D., Liao, Z., Yu, X., Guo, F., Yu, R., Xu, M.-Z., Xia, Y., & Gao, W. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.131036 · Cited by 11
Molecular Dynamics of Anthraquinone DNA Intercalators with Polyethylene Glycol Side Chains
Beckford, S. J., & Dixon, D. W. (2012) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/073911012010525031 · Cited by 11
Challenges in developing small-molecule quadruplex therapeutics
Neidle, S. (2020) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.05.005 · Cited by 16
Self-citationTelomerase in Cancer Diagnosis and Therapy
Burger, A. M. (1999) · BioDrugs · doi:10.2165/00063030-199912060-00001 · Cited by 11
“[6] The most promising class of novel telomerase inhibitory compounds are the G-quartet interactive agents that are currently being developed for entry into phase I by von Hoff and others at the San Antonio Institute for Drug Development.”
BackgroundPrinciples of Small Molecule-DNA Recognition
Neidle, S. (2008) · Elsevier eBooks · doi:10.1016/b978-012369507-9.50006-6 · Cited by 11
Self-citationTelomerase inhibitors: a new option for chemotherapy
Chen, Z., & Corey, D. R. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87173-7 · Cited by 15
Telomerase inhibitors: a new option for chemotherapy
Chen, Z. J., & Corey, D. R. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87294-9 · Cited by 11
Roy, S., Pramanik, P., & Bhattacharya, S. (2025) · Biochimie · doi:10.1016/j.biochi.2025.04.004 · Cited by 11
Chang, T., & Chang, C. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-363-9_12 · Cited by 10
Computational and Experimental Characterization of rDNA and rRNA G-Quadruplexes
Green, A. T., Pickard, A. J., Li, R., MacKerell, A. D., Bierbach, U., & Cho, S. S. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c08340 · Cited by 10
“…Pol I-mediated transcription by small molecules, such as G-quadruplex binders, represents an attractive therapeutic strategy 31 –133 Many chemotherapeutics derived from anthraquinones 34 , fluorenones 35 , acridines 36 , and other polyaromatic chromophores show a high affinity for G-quadruplexes.”
BackgroundSatange, R., Rode, A. B., & Hou, M. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.117094 · Cited by 11
Chung, Y.-L., Pan, C., Liou, W.-H., Sheu, M., Lin, W., Chen, T., Huang, H., & Wu, C. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13096fp · Cited by 10
The Cytotoxic Effects of Single-Stranded Telomere Mimics on OMA-BL1 Cells
Page, T. J., Mata, J. E., Bridge, J. A., Siebler, J., Neff, J. R., & Iversen, P. L. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4613 · Cited by 10
Fletcher, T. M., Trevino, A. V., & WOYNAROWSKI, J. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1626 · Cited by 11
Sengupta, P., Dutta, A., Suseela, Y. V., Roychowdhury, T., Banerjee, N., Dutta, A., Halder, S., Jana, K., Mukherjee, G., Chattopadhyay, S., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05046-6 · Cited by 9
“G-Quadruplex (G4) nucleic acids have long been identified as attractive therapeutic targets in anticancer research [30].”
New acridone derivatives to target telomerase and oncogenes – an anticancer approach
Marques, T., Salvador, D., Oliveira, H., Serra, V. V., Paradis, N. J., Wu, C. F., Silva, V. L. M., & Ramos, C. I. V. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00959b · Cited by 9
“24 Fig.”
Harnessing G-quadruplex ligands for lung cancer treatment: A comprehensive overview
Figueiredo, J., Djavaheri‐Mergny, M., Ferret, L., Mergny, J., & Cruz, C. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103808 · Cited by 12
Sharawy, M., & Consta, S. (2018) · The Journal of Chemical Physics · doi:10.1063/1.5050534 · Cited by 9
Sasaki, S., Ma, Y., Ishizuka, T., Bao, H., Hirokawa, T., Xu, Y., Tera, M., & Nagasawa, K. (2020) · RSC Advances · doi:10.1039/d0ra09413g · Cited by 9
Duyar, H., Portakal, H. S., Yalçın, E., Kanat, B., Doluca, O., & Seferoğlu, Z. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127824 · Cited by 9
Single-molecule analysis of DNA structures using nanopore sensors
Li, F., Luo, Y., Xi, G., Fu, J., & Tu, J. (2022) · Chinese Journal of Analytical Chemistry · doi:10.1016/j.cjac.2022.100089 · Cited by 9
Sheu, S., Huang, C., Zhou, J.-K., & Yang, D. (2014) · Biopolymers · doi:10.1002/bip.22497 · Cited by 9
Xu, B., Zhao, C., Chen, Y., Tateishi‐Karimata, H., Ren, J., Sugimoto, N., & Qu, X. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201404854 · Cited by 9
Télomères : un Nobel pour le début de la fin
Rajpar, S., Guittat, L., & Mergny, J. (2011) · Bulletin du Cancer · doi:10.1684/bdc.2011.1378 · Cited by 9
Huang, H., Huang, K.-F., Lee, C.-C., Chen, C., Li, C.-L., & Lin, J. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283324d0a · Cited by 9
Exploring the Binding of Calothrixin A to the G-Quadruplex from the c-myc Oncogene Promotor*
Owen, E. A., & Keniry, M. A. (2009) · Australian Journal of Chemistry · doi:10.1071/ch09169 · Cited by 9
G-Quadruplex DNA-binding quaternary alkaloids from Tylophora atrofolliculata
Chen, C.-Y., Bai, L., Ke, Z., Liu, Y., Wang, J., & Jiang, Z. (2016) · RSC Advances · doi:10.1039/c6ra21056b · Cited by 9
Peng, H., Zhang, Y., Luo, Q., Wang, X., & You, H. (2024) · Biophysics Reports · doi:10.52601/bpr.2024.240018 · Cited by 9
“These ligands include diverse chemical classes such as 2,6-diamido anthraquinones (Sun et al. 1997), porphyrin derivative TmPyP4 (Siddiqui-Jain et al. 2002), perylene derivative PIPER (Rangan et al. 2001), acridine derivative BRACO-19 (Moore et al. 2006) and quinoline derivative pyrido-statin (PDS)…”
BackgroundPolymorphism and Ligand Binding Modulate Fast Dynamics of Human Telomeric G-Quadruplexes
Bertini, L., Libera, V., Ripanti, F., Natali, F., Paolantoni, M., Orecchini, A., Nucara, A., Petrillo, C., Comez, L., & Paciaroni, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054280 · Cited by 8
“The fast dynamics of Tel22 in the presence of these two ions was also studied upon complexation with BRACO19, which is a potential anticancer drug [39].”
BackgroundTranslating G-quadruplex ligands from bench to bedside: a Stephen Neidle’s legacy
Monchaud, D. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03310-3 · Cited by 8
“Chem . a seminal article (now cumulating >700 citations) on the very fi rst prototype of a G4 ligand, a 2,6-diaminoanthraquinone able to stabilize the telomeric G4 and, in doing so, inhibit the telomerase enzyme through an original mechanism [12].”
Targeting G-quadruplex DNA and B-DNA with a natural alkaloid: a comparative spectroscopic study
Mandal, P., Bhattacharya, M., & Chowdhury, J. (2016) · RSC Advances · doi:10.1039/c6ra22776g · Cited by 8
Pokhrel, P., Sasaki, S., Hu, C., Karna, D., Pandey, S., Ma, Y., Nagasawa, K., & Mao, H. (2022) · Analytical Biochemistry · doi:10.1016/j.ab.2022.114693 · Cited by 8
Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy—An Overview
Salerno, S., Barresi, E., Baglini, E., Poggetti, V., Taliani, S., & Settimo, F. D. (2022) · Biomedicines · doi:10.3390/biomedicines10112932 · Cited by 8
Zambre, V. P., Giridhar, R., & Yadav, M. R. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0447-6 · Cited by 8
“Stabilization of telomeric G-quadruplex by quadruplex-binding ligands inhibit telomerase function (Sun et al., 1997).”
BackgroundDeepa, P., Kolandaivel, P. G., & Senthilkumar, K. (2010) · International Journal of Quantum Chemistry · doi:10.1002/qua.22720 · Cited by 8
Yaku, H., Murashima, T., Miyoshi, D., & Sugimoto, N. (2013) · Molecules · doi:10.3390/molecules181011751 · Cited by 8
“G-quadruplex does not serve as a substrate DNA for telomerase [44]; therefore, G-quadruplex ligands that inhibit telomerase activity are promising as anticancer drugs [45].”
BackgroundBeals, N., Farhath, M. M., Kharel, P., Croos, B., Mahendran, T., Johnson, J., & Basu, S. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.05.013 · Cited by 8
Quantifying Interactions Between G-Quadruplex DNA and Transition-Metal Complexes
Kieltyka, R. E., Englebienne, P., Moitessier, N., & Sleiman, H. F. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-363-9_14 · Cited by 8
From Triads to Tools: A Comprehensive Review of the Expanding Roles of G-Triplex Structures
Myhre, M. W., Das, M. K., Williams, E. P., David, W. M., & Kerwin, S. M. (2025) · Molecules · doi:10.3390/molecules30214303 · Cited by 7
“Early work on human telomeres revealed that ligand-mediated stabilization of telomeric G4 DNAs may inhibit the activity of telomerase, an enzyme responsible for telomere extension that is overexpressed in most cancer cells and contributes to cell immortality [11].”
Self-citationGłuszyńska, A., Rajczak, E., & Juskowiak, B. (2013) · Chemical Papers · doi:10.2478/s11696-013-0343-7 · Cited by 7
A human telomeric G-quadruplex-based electronic nanoswitch for the detection of anticancer drugs
Bagheryan, Z., Raoof, J. B., Ojani, R., & Rezaei, P. (2015) · The Analyst · doi:10.1039/c4an02010c · Cited by 7
Metadata
- Authors
- Sun, D., Thompson, B., Cathers, B. E., Salazar, M., Kerwin, S. M., Trent, J. O., Jenkins, T. C., Neidle, S., & Hurley, L. H.
- Affiliations
- The University of Texas at Austin (US)
- ORCID
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1997-07-01
- Volume
- 40
- Issue
- 14
- Pages
- 2113-2116
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2025811126
- Semantic Scholar
- 67b8d8f99c37d9233c470812b601e6637423725f
- Cited by
- 794
- References
- 21
- Citations by year
- 2026: 12 · 2025: 10 · 2024: 29 · 2023: 19 · 2022: 46 · 2021: 46 · 2020: 35 · 2019: 27 · 2018: 27 · 2017: 20 · 2016: 36 · 2015: 42 · 2014: 38 · 2013: 33 · 2012: 39
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institutes of Health (7u19ca067760-05)
- National Cancer Institute (CA-67760, CA 49751)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Keywords
- G-quadruplex, human telomerase reverse transcriptase, telomere replication, anticancer agents
- MeSH terms
- Anthraquinones, Base Sequence, DNA, Enzyme Inhibitors, Humans, Nucleic Acid Conformation, Nucleic Acid Denaturation, Oligodeoxyribonucleotides, Molecular Structure, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.